MX364732B - Vacuna contra el tumor de wilms 1. - Google Patents
Vacuna contra el tumor de wilms 1.Info
- Publication number
- MX364732B MX364732B MX2015007573A MX2015007573A MX364732B MX 364732 B MX364732 B MX 364732B MX 2015007573 A MX2015007573 A MX 2015007573A MX 2015007573 A MX2015007573 A MX 2015007573A MX 364732 B MX364732 B MX 364732B
- Authority
- MX
- Mexico
- Prior art keywords
- seq
- protein
- nucleic acid
- acid sequence
- fragment
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
- A61K39/001152—Transcription factors, e.g. SOX or c-MYC
- A61K39/001153—Wilms tumor 1 [WT1]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Oncology (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
La presente invención se refiere a una molécula de ácido nucleico aislada, caracterizada porque comprende una o más secuencia de ácido nucleico seleccionadas del grupo que consiste de: (i) una secuencia de ácido nucleico que codifica la proteína establecida en la SEQ ID NO: 2, (ii) una secuencia de ácido nucleico que codifica un fragmento de la proteína establecida en la SEQ ID NO: 2 en donde el fragmento comprende al menos 90% de la longitud completa de la proteína establecida en la SEQ ID NO: 2; (iii) una secuencia de ácido nucleico que codifica una proteína que es al menos 90% idéntica a la proteína establecida en la SEQ ID NO: 2 sobre la longitud completa de la SEQ ID NO: 2; (iv) una secuencia de ácido nucleico que codifica un fragmento de una proteína que es al menos 98% idéntica a la proteína establecida en la SEQ ID NO: 2 en donde la longitud del fragmento es al menos 90% de la longitud completa de la proteína establecida en la SEQ ID NO: 2; (v) una secuencia de ácido nucleico que codifica la proteína establecida en la SEQ IE NO: 4; (vi) una secuencia de ácido nucleico que codifica un fragmento de SEQ ID NO: 4 en donde el fragmento comprende al menos 90% de la longitud completa de la proteína establecida en la SEQ ID NO: 4; (vii) una secuencia de ácido nucleico que codifica una proteína que es al menos 98% idéntica a la proteína establecida en la SEQ ID NO: 4 sobre la longitud completa de la SEQ ID NO: 4; y (viii) una secuencia de ácido nucleico que codifica un fragmento de una proteína que es 98% idéntica a la proteína establecida en la SEQ ID NO: 4 en donde la longitud del fragmento es al menos 90% de la longitud completa de la proteína establecida en la SEQ ID NO: 4.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261737094P | 2012-12-13 | 2012-12-13 | |
| PCT/US2013/075141 WO2014093897A1 (en) | 2012-12-13 | 2013-12-13 | Wt1 vaccine |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX2015007573A MX2015007573A (es) | 2016-03-15 |
| MX364732B true MX364732B (es) | 2019-05-06 |
Family
ID=50935008
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2015007573A MX364732B (es) | 2012-12-13 | 2013-12-13 | Vacuna contra el tumor de wilms 1. |
Country Status (12)
| Country | Link |
|---|---|
| US (3) | US10220082B2 (es) |
| EP (2) | EP3782640A1 (es) |
| JP (4) | JP6523174B2 (es) |
| KR (3) | KR102258021B1 (es) |
| CN (1) | CN104812401B (es) |
| AU (1) | AU2013358947B2 (es) |
| BR (1) | BR112015013004B1 (es) |
| CA (1) | CA2888648C (es) |
| MX (1) | MX364732B (es) |
| PL (1) | PL2931304T3 (es) |
| SI (1) | SI2931304T1 (es) |
| WO (2) | WO2014093886A1 (es) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2889723A1 (en) | 2012-12-13 | 2014-06-19 | The Trustees Of The University Of Pennsylvania | Dna antibody constructs and method of using same |
| CA2888648C (en) * | 2012-12-13 | 2021-06-08 | The Trustees Of The University Of Pennsylvania | Wt1 vaccine |
| AU2014228405B2 (en) * | 2013-03-15 | 2017-05-11 | The Trustees Of The University Of Pennsylvania | Cancer vaccines and methods of treatment using the same |
| SG11201604719WA (en) * | 2013-12-13 | 2016-07-28 | Univ Pennsylvania | Dna antibody constructs and method of using same |
| WO2016089862A1 (en) | 2014-12-01 | 2016-06-09 | The Trustees Of The University Of Pennsylvania | Dna antibody constructs and method of using same |
| PT3737397T (pt) * | 2017-12-13 | 2023-02-28 | Inovio Pharmaceuticals Inc | Vacinas anticancro direcionadas contra prame e utilizações das mesmas |
| US11338028B2 (en) * | 2017-12-13 | 2022-05-24 | Inovio Pharmaceuticals, Inc. | Cancer vaccines targeting LEMD1 and uses thereof |
| IL310808A (en) | 2021-08-13 | 2024-04-01 | Inovio Pharmaceuticals Inc | Combination therapy to treat brain cancer |
| WO2023201199A2 (en) * | 2022-04-11 | 2023-10-19 | The Johns Hopkins University | Tuberculosis vaccines |
| CN115845039A (zh) * | 2022-07-01 | 2023-03-28 | 可蓝赛生物医药(上海)有限公司 | 一种广谱多肽肿瘤疫苗组成 |
| CN116139260A (zh) * | 2023-03-02 | 2023-05-23 | 广东龄值生物科技有限公司 | 一种wt1肿瘤疫苗及其制备方法与应用 |
Family Cites Families (56)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US21579A (en) | 1858-09-21 | Rotary valve fob steam-engines | ||
| US3805783A (en) | 1971-02-12 | 1974-04-23 | A Ismach | Hand powered hypodermic jet injector gun |
| US4342310A (en) | 1980-07-08 | 1982-08-03 | Istvan Lindmayer | Hydro-pneumatic jet injector |
| US4554101A (en) | 1981-01-09 | 1985-11-19 | New York Blood Center, Inc. | Identification and preparation of epitopes on antigens and allergens on the basis of hydrophilicity |
| US4447223A (en) | 1982-04-16 | 1984-05-08 | Cct Associates | Medicament implant applicator |
| US5703055A (en) | 1989-03-21 | 1997-12-30 | Wisconsin Alumni Research Foundation | Generation of antibodies through lipid mediated DNA delivery |
| US5545130A (en) | 1992-04-08 | 1996-08-13 | Genetronics, Inc. | Flow through electroporation method |
| EP0646178A1 (en) | 1992-06-04 | 1995-04-05 | The Regents Of The University Of California | expression cassette with regularoty regions functional in the mammmlian host |
| US5273525A (en) | 1992-08-13 | 1993-12-28 | Btx Inc. | Injection and electroporation apparatus for drug and gene delivery |
| AU675702B2 (en) | 1993-01-26 | 1997-02-13 | Leslie R. Coney | Compositions and methods for delivery of genetic material |
| US5593972A (en) | 1993-01-26 | 1997-01-14 | The Wistar Institute | Genetic immunization |
| US5702359A (en) | 1995-06-06 | 1997-12-30 | Genetronics, Inc. | Needle electrodes for mediated delivery of drugs and genes |
| US5993434A (en) | 1993-04-01 | 1999-11-30 | Genetronics, Inc. | Method of treatment using electroporation mediated delivery of drugs and genes |
| US5679647A (en) | 1993-08-26 | 1997-10-21 | The Regents Of The University Of California | Methods and devices for immunizing a host against tumor-associated antigens through administration of naked polynucleotides which encode tumor-associated antigenic peptides |
| US5505697A (en) | 1994-01-14 | 1996-04-09 | Mckinnon, Jr.; Charles N. | Electrically powered jet injector |
| US5962428A (en) | 1995-03-30 | 1999-10-05 | Apollon, Inc. | Compositions and methods for delivery of genetic material |
| US5869326A (en) | 1996-09-09 | 1999-02-09 | Genetronics, Inc. | Electroporation employing user-configured pulsing scheme |
| US6261281B1 (en) | 1997-04-03 | 2001-07-17 | Electrofect As | Method for genetic immunization and introduction of molecules into skeletal muscle and immune cells |
| JP2001520537A (ja) | 1997-04-03 | 2001-10-30 | エレクトロフェクト・アクティーゼルスカブ | 医薬品と核酸の骨格筋への導入方法 |
| HUP0004589A3 (en) | 1997-06-30 | 2003-08-28 | Centre Nat Rech Scient | Improved method for transferring nucleic acid into the striped muscle and combination therefor |
| US6216034B1 (en) | 1997-08-01 | 2001-04-10 | Genetronics, Inc. | Method of programming an array of needle electrodes for electroporation therapy of tissue |
| US6241701B1 (en) | 1997-08-01 | 2001-06-05 | Genetronics, Inc. | Apparatus for electroporation mediated delivery of drugs and genes |
| US6055453A (en) | 1997-08-01 | 2000-04-25 | Genetronics, Inc. | Apparatus for addressing needle array electrodes for electroporation therapy |
| US6208893B1 (en) | 1998-01-27 | 2001-03-27 | Genetronics, Inc. | Electroporation apparatus with connective electrode template |
| US6009347A (en) | 1998-01-27 | 1999-12-28 | Genetronics, Inc. | Electroporation apparatus with connective electrode template |
| US6120493A (en) | 1998-01-27 | 2000-09-19 | Genetronics, Inc. | Method for the introduction of therapeutic agents utilizing an electroporation apparatus |
| EP1100579B1 (en) | 1998-07-13 | 2015-09-02 | Inovio Pharmaceuticals, Inc. | Skin and muscle-targeted gene therapy by pulsed electrical field |
| EP1102608A4 (en) | 1998-07-13 | 2008-09-17 | Genetronics Inc | METHOD AND APPARATUS FOR THE ELECTRICALLY SUPPORTED SURFACE APPLICATION OF COSMETIC MEANS |
| US6192270B1 (en) | 1998-08-14 | 2001-02-20 | Genetronics, Inc. | Apparatus and method for the delivery of drugs and genes into tissue |
| US7655249B2 (en) | 1998-09-30 | 2010-02-02 | Corixa Corporation | Compositions and methods for WT1 specific immunotherapy |
| US20030235557A1 (en) | 1998-09-30 | 2003-12-25 | Corixa Corporation | Compositions and methods for WT1 specific immunotherapy |
| US20030039635A1 (en) * | 1998-09-30 | 2003-02-27 | Corixa Corporation | Compositions and methods for WT1 specific immunotherapy |
| US6150148A (en) | 1998-10-21 | 2000-11-21 | Genetronics, Inc. | Electroporation apparatus for control of temperature during the process |
| US7171264B1 (en) | 1999-05-10 | 2007-01-30 | Genetronics, Inc. | Intradermal delivery of active agents by needle-free injection and electroporation |
| WO2000067837A1 (en) | 1999-05-10 | 2000-11-16 | Gentronics, Inc. | Method of electroporation-enhanced delivery of active agents |
| US20070037165A1 (en) * | 2000-09-08 | 2007-02-15 | Applera Corporation | Polymorphisms in known genes associated with human disease, methods of detection and uses thereof |
| US7553494B2 (en) | 2001-08-24 | 2009-06-30 | Corixa Corporation | WT1 fusion proteins |
| JP3543326B2 (ja) | 2001-08-30 | 2004-07-14 | ソニー株式会社 | 情報処理装置および方法、情報処理システム、情報配信装置、記録媒体、並びにプログラム |
| US8209006B2 (en) | 2002-03-07 | 2012-06-26 | Vgx Pharmaceuticals, Inc. | Constant current electroporation device and methods of use |
| US7245963B2 (en) | 2002-03-07 | 2007-07-17 | Advisys, Inc. | Electrode assembly for constant-current electroporation and use |
| US7328064B2 (en) | 2002-07-04 | 2008-02-05 | Inovio As | Electroporation device and injection apparatus |
| CA2504593C (en) | 2002-11-04 | 2016-08-09 | Advisys, Inc. | Synthetic muscle promoters with activities exceeding naturally occurring regulatory sequences in cardiac cells |
| EP1628749B1 (en) | 2003-05-30 | 2019-07-31 | VGXI, Inc. | Devices and methods for biomaterial production |
| US20060216722A1 (en) * | 2005-03-25 | 2006-09-28 | Christer Betsholtz | Glomerular expression profiling |
| ES2542141T3 (es) * | 2005-10-17 | 2015-07-31 | Sloan Kettering Institute For Cancer Research | Péptidos WT1 de unión a HLA de clase II, y composiciones y métodos que los comprenden |
| ES2587980T3 (es) * | 2006-02-22 | 2016-10-28 | International Institute Of Cancer Immunology, Inc | Péptido WT1 con restricción HLA-A*3303 y composición farmacéutica que lo contiene |
| ES2679127T3 (es) * | 2007-12-05 | 2018-08-22 | International Institute Of Cancer Immunology, Inc. | Composición vacunal contra el cáncer |
| US8298820B2 (en) | 2010-01-26 | 2012-10-30 | The Trustees Of The University Of Pennsylvania | Influenza nucleic acid molecules and vaccines made therefrom |
| EP2603581B1 (en) | 2010-08-11 | 2019-07-17 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Cocultures of cumulus cells and embryos during in vitro fertilization procedures |
| CA2817709C (en) | 2010-11-12 | 2021-06-01 | The Trustees Of The University Of Pennsylvania | Consensus prostate antigens, nucleic acid molecule encoding the same and vaccine and uses comprising the same |
| JP6099573B2 (ja) * | 2011-01-31 | 2017-03-22 | ザ トラスティーズ オブ ザ ユニバーシティ オブ ペンシルバニア | 新規なヘルペス抗原をコードする核酸分子、それを含むワクチン及びその使用方法 |
| CA2861206C (en) * | 2012-01-13 | 2021-07-06 | Richard J. O'reilly | Immunogenic wt-1 peptides and methods of use thereof |
| GB2504774A (en) | 2012-08-10 | 2014-02-12 | Munster Simms Eng Ltd | Diaphragm pump with integral motor housing and rear pump housing |
| CA2888648C (en) * | 2012-12-13 | 2021-06-08 | The Trustees Of The University Of Pennsylvania | Wt1 vaccine |
| AU2014228405B2 (en) * | 2013-03-15 | 2017-05-11 | The Trustees Of The University Of Pennsylvania | Cancer vaccines and methods of treatment using the same |
| TWI548337B (zh) | 2015-10-16 | 2016-09-01 | 技嘉科技股份有限公司 | 散熱模組、顯示卡組件及電子裝置 |
-
2013
- 2013-12-13 CA CA2888648A patent/CA2888648C/en active Active
- 2013-12-13 MX MX2015007573A patent/MX364732B/es active IP Right Grant
- 2013-12-13 KR KR1020157018709A patent/KR102258021B1/ko active Active
- 2013-12-13 PL PL13861986T patent/PL2931304T3/pl unknown
- 2013-12-13 SI SI201331911T patent/SI2931304T1/sl unknown
- 2013-12-13 AU AU2013358947A patent/AU2013358947B2/en active Active
- 2013-12-13 KR KR1020237008231A patent/KR102877281B1/ko active Active
- 2013-12-13 CN CN201380061939.2A patent/CN104812401B/zh active Active
- 2013-12-13 BR BR112015013004-6A patent/BR112015013004B1/pt active IP Right Grant
- 2013-12-13 JP JP2015548015A patent/JP6523174B2/ja active Active
- 2013-12-13 WO PCT/US2013/075127 patent/WO2014093886A1/en not_active Ceased
- 2013-12-13 EP EP20196622.3A patent/EP3782640A1/en active Pending
- 2013-12-13 WO PCT/US2013/075141 patent/WO2014093897A1/en not_active Ceased
- 2013-12-13 EP EP13861986.1A patent/EP2931304B1/en active Active
- 2013-12-13 US US14/651,492 patent/US10220082B2/en active Active
- 2013-12-13 KR KR1020217015640A patent/KR102509444B1/ko active Active
-
2018
- 2018-12-17 US US16/221,707 patent/US11638747B2/en active Active
-
2019
- 2019-04-25 JP JP2019084715A patent/JP7011241B2/ja active Active
-
2022
- 2022-01-04 JP JP2022000162A patent/JP2022048162A/ja active Pending
-
2023
- 2023-01-31 US US18/162,104 patent/US20230293653A1/en active Pending
-
2024
- 2024-07-19 JP JP2024115981A patent/JP2024150611A/ja active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX364732B (es) | Vacuna contra el tumor de wilms 1. | |
| MX346862B (es) | Secuencias consenso de envoltura de vih y método para usar las mismas. | |
| MX356792B (es) | Elementos de regulacion de plantas y sus usos. | |
| ES2618783T3 (es) | Construcción de ADN inmunomodulador no codificante | |
| PY18107830A (es) | Variantes de alfa-amilasa y polinucleótidos que las codifican | |
| AR094141A1 (es) | Composiciones y metodos para proteinas de accion prolongada | |
| ES2691091T3 (es) | Vacuna conjugada de péptido antigénico de WT1 | |
| MX387336B (es) | Enzimas de clostridium histolyticum y metodos para el uso de los mismos. | |
| UY33665A (es) | Derivado peptídico | |
| ES2693321T3 (es) | Péptidos antiinflamatorios y composición que comprende los mismos | |
| CL2019000980A1 (es) | Oligonucleotidos antisentido de al menos 10 nucleotidos que inhiben de la señalización del gen tgf-ii o una región del arnm que lo codifica. (divisional solicitud 201701233). | |
| EA201500659A1 (ru) | Ацетилтрансферазы и их применение для получения каротиноидов | |
| ECSP12011577A (es) | Produccion recombinante de péptidos | |
| MX371403B (es) | Moleculas de andamiaje a base de fibronectina estabilizada. | |
| AR069821A1 (es) | Composiciones y metodos de uso de la interferencia de arn para el control de nematodos | |
| AR128395A2 (es) | Péptidos novedosos capaces de inducir la formación de anticuerpos contra pcsk9 | |
| ES2383716T3 (es) | Composiciones y métodos que utilizan ARN de interferencia de un gen del tipo OPR3 para el control de nemátodos | |
| CY1124110T1 (el) | Συνθεσεις και μεθοδοι μεταλλαγμενου παραγοντα viii | |
| ECSP10010082A (es) | Udp-glucuronil transferasa y polinucleotido de codificacion | |
| IN2015DN03206A (es) | ||
| UY39980A (es) | Manipulación de la Auto-incompatibilidad en Plantas | |
| AR100310A1 (es) | Moléculas para transporte de antígeno modular mejoradas y sus usos | |
| AR093923A1 (es) | Polipeptidos con actividad fosfolipasa c y polinucleotidos que los codifican | |
| CU20170038A7 (es) | Derivados de adrenomedulina estabililzados especialmente útiles en el tratamiento y/o prevención de trastornos cardiovasculares, edematosos y/o inflamatorios | |
| AR091160A1 (es) | Gen dirigent eg261 y sus ortologos y paralogos y sus usos en la resistencia a patogenos en plantas |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |